• Home
  • Store
    • Total Access Subscriptions
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Fact Sheet

Articles Tagged with ''Fact Sheet''

Clinical Guidance

Table: Psychiatric Medications in Pregnancy and Lactation

April 24, 2026
Victoria Hendrick, MD and Daniel Carlat, MD

Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

  • Table: Psychiatric Medications in Pregnancy and Lactation

  • Read More
    Fact Sheet

    Use of Psychiatric Medications in Breastfeeding Patients

    April 24, 2026
    Victoria Hendrick, MD and Daniel Carlat, MD

    Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    When new mothers are admitted to the inpatient psychiatric unit, they might ask about the safety of taking psychiatric medications while breastfeeding.


    Read More
    Fact Sheet

    Depression in Pregnancy: Diagnosis and Treatment

    April 24, 2026
    Victoria Hendrick, MD and Daniel Carlat, MD

    Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    Prenatal depression is common, affecting 10%–15% of pregnant patients.




    Read More
    Fact Sheet

    PTSD Diagnosis and Treatment

    April 24, 2026
    Victoria Hendrick, MD and Daniel Carlat, MD

    Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    Many of your patients will most likely have been exposed to significant trauma, such as adverse childhood experiences, domestic or sexual violence, and the hardships associated with homelessness or substance use.



    Read More
    Fact Sheet

    Dissociative Identity Disorder: Diagnosis and Treatment

    April 24, 2026
    Daniel Carlat, MD

    Dr. Carlat has no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    Occasionally you will encounter patients who report having multiple personalities or distinct identities, also called alters. Formerly called “multiple personality disorder,” this condition is now termed dissociative identity disorder (DID). 


    Read More
    Fact Sheet

    Topiramate (Eprontia, Qudexy XR, Topamax, Trokendi XR) Fact Sheet

    April 21, 2026
    Michael Weaver, MD, FASAM, Daniel Carlat, MD, and Talia Puzantian, PharmD, BCPP

    Dr. Carlat, Dr. Weaver, and Dr. Puzantian have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    Naltrexone, an opioid antagonist, is the first-line medication for alcohol use disorder (AUD)—though it is also approved for opioid use disorder (OUD).




    Read More
    Fact Sheet

    Naltrexone (ReVia, Vivitrol) Fact Sheet

    April 21, 2026
    Michael Weaver, MD, FASAM, Daniel Carlat, MD, and Talia Puzantian, PharmD, BCPP

    Dr. Carlat, Dr. Weaver, and Dr. Puzantian have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    Naltrexone, an opioid antagonist, is the first-line medication for alcohol use disorder (AUD)—though it is also approved for opioid use disorder (OUD).




    Read More
    Fact Sheet

    Gabapentin (Gralise, Horizant, Neurontin) Fact Sheet

    April 21, 2026
    Michael Weaver, MD, FASAM, Daniel Carlat, MD, and Talia Puzantian, PharmD, BCPP

    Dr. Carlat, Dr. Weaver, and Dr. Puzantian have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    Gabapentin is effective as an off-label medication to ease alcohol withdrawal symptoms and to reduce cravings over the long term in patients with alcohol use disorder (AUD).




    Read More
    Fact Sheet

    Disulfiram (Antabuse) Fact Sheet

    April 21, 2026
    Michael Weaver, MD, FASAM, Daniel Carlat, MD, and Talia Puzantian, PharmD, BCPP

    Dr. Carlat, Dr. Weaver, and Dr. Puzantian have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    Disulfiram is an aversive treatment, causing a buildup of ethanol’s metabolite acetaldehyde in the serum, which in turn causes symptoms such as flushing, dizziness, nausea, and vomiting if patient consumes alcohol.



    Read More
    Fact Sheet

    Acamprosate (Campral) Fact Sheet [G]

    April 21, 2026
    Michael Weaver, MD, FASAM, Daniel Carlat, MD, and Talia Puzantian, PharmD, BCPP

    Dr. Carlat, Dr. Weaver, and Dr. Puzantian have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    Acamprosate is best for maintaining abstinence in patients who have already quit drinking, but it can be helpful even after patients relapse. Naltrexone is the better choice for patients who are still drinking, since it is better at helping patients quit. Acamprosate is preferred over naltrexone in patients with hepatic impairment.


    Read More
    Previous 1 2 3 4 5 6 7 8 9 … 56 57 Next
    Carlat Total Access Subscriptions: Get access to every article on the website.

    Complete access to every article you search on the website.

    Shop for Total Access
    Free Psychiatry Updates
    The latest unbiased psychiatric information sent to your inbox.
    Specify Your Interests
    Featured Book
    • MFB8e_SpiralCover.png

      Medication Fact Book for Psychiatric Practice, Eighth Edition (2026)

      Updated 2026 prescriber's guide.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • supportive psychotherapy Dalle 11082023.jpg
      Psychology and Social Work

      Treating BPD Series, Episode 2: Transference-Focused Psychotherapy—From Splitting to Coherence with Frank Yeomans, MD, PhD

      In this episode, Dr. Frank Yeomans offers a deep dive into the theory and clinical practice of TFP as a treatment for Borderline Personality Disorder.

      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.